The study will compare the effectiveness of FDA approved medicines for hepatitis C (HCV) to find out if they work equally well under real-world conditions—that is outside of standard clinical trials. Patients can consent to participate in the study and be randomly assigned to receive one of the HCV therapies in their current community or academic (university) clinics. The study will follow patient reported outcomes using surveys that can be completed on devices with Internet access or by telephone. Once participants are randomized (assigned to a HCV treatment by a computer program), all medical care, laboratory testing, and any disease or side effect management will be performed in the usual manner by your HCV treatment provider.
A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders
Study of Oral Treatments for Hepatitis C (PRIORITIZE)
To read the entire clinical trial description, click here…